Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 5/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 5/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 5/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 5/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.44 |
| ▸ | GRIN2C | Q14957 | 5/20 | 0.44 |
| ▸ | GRIN3A | Q8TCU5 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | SLC22A2 | O15244 | 2/20 | 0.44 |
| ▸ | SLC47A1 | Q96FL8 | 2/20 | 0.44 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | STAT6 | P42226 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL27637741 | 0.96 | GRIN2D (0.42) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Butane SCHEMBL27880144 | 0.85 | GRIN2D (0.36) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL6415574 | 0.79 | — | — | |
| SCHEMBL2574454 | 0.79 | GRIN2D (0.33) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL26031919 | 0.78 | GRIN2D (0.31) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL17226612 | 0.76 | — | — | |
| SCHEMBL1221991 | 0.74 | LMNA (0.32) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL12861230 | 0.74 | LMNA (0.32) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL16199926 | 0.74 | LMNA (0.32) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL12861223 | 0.74 | LMNA (0.32) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12460126-B2 | Quantum dot, method of preparing the quantum dot, composition including the quantum dot, optical member including the quantum dot, and electronic apparatus including the quantum dot | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-11-04 | — | — | US | claimed |
| CN-119661366-A | Preparation method and application of amantadine carbonate | 李果 | 2025-03-21 | — | — | CN | claimed |
| CN-119661365-A | Novel method for producing amantadine hydrochloride | 李果 | 2025-03-21 | — | — | CN | claimed |
| CN-119661364-A | Method for producing high-purity amantadine | 李果 | 2025-03-21 | — | — | CN | claimed |
| US-20240383856-A1 | INHIBITORS OF TRANSGLUTAMINASES | ZEDIRA GMBH (DE) | 2024-11-21 | — | — | US | claimed |
| US-20240376055-A1 | INHIBITORS OF TRANSGLUTAMINASES | ZEDIRA GMBH (DE) | 2024-11-14 | — | — | US | claimed |
| US-20240317708-A1 | INHIBITORS OF TRANSGLUTAMINASES | ZEDIRA GMBH (DE) | 2024-09-26 | — | — | US | claimed |
| EP-4192812-B1 | INHIBITORS OF TRANSGLUTAMINASES | ZEDIRA GMBH (DE) | 2024-09-04 | — | — | EP | claimed |
| US-20240270715-A1 | INHIBITORS OF TRANSGLUTAMINASES | ZEDIRA GMBH (DE) | 2024-08-15 | — | — | US | claimed |
| EP-4192813-B1 | INHIBITORS OF TRANSGLUTAMINASES | ZEDIRA GMBH (DE) | 2024-08-14 | — | — | EP | claimed |
| EP-4192814-B1 | INHIBITORS OF TRANSGLUTAMINASES | ZEDIRA GMBH (DE) | 2024-08-07 | — | — | EP | claimed |
| WO-2023204357-A1 | SURFACE-MODIFIED METAL OXIDE AND INK COMPOSITION COMPRISING SAME | 한남대학교 산학협력단 | 2023-10-26 | — | — | WO | claimed |
| US-20230011105-A1 | QUANTUM DOT, METHOD OF PREPARING THE QUANTUM DOT, COMPOSITION INCLUDING THE QUANTUM DOT, OPTICAL MEMBER INCLUDING THE QUANTUM DOT, AND ELECTRONIC APPARATUS INCLUDING THE QUANTUM DOT | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-01-12 | — | — | US | claimed |
| CN-115572595-A | Quantum dot, method for producing quantum dot, composition, optical member, and electronic device | 三星显示有限公司 | 2023-01-06 | — | — | CN | claimed |
| US-20200331762-A1 | Diamond-Like Carbon Film | APPLIED MATERIALS, INC (US) | 2020-10-22 | — | — | US | claimed |
| US-20200079802-A1 | ORGANOSILICON ON SOLID OXIDES, AND RELATED COMPLEXES, COMPOSITIONS, METHODS AND SYSTEMS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-03-12 | — | — | US | claimed |
| US-20180354804-A1 | Diamond-Like Carbon Film | APPLIED MATERIALS, INC. | 2018-12-13 | — | — | US | claimed |
| US-12516892-B2 | Inverted barocaloric effects | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-01-06 | — | — | US | disclosed |
| US-4284558-A | Chemical process for fluorinating a tertiary carbon atom in the steroid nucleus | RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY, INC. (US) | 1981-08-18 | — | — | US | disclosed |
| US-4036864-A | Chemical process | RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY INC. (US) | 1977-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200079802-A1 | ORGANOSILICON ON SOLID OXIDES, AND RELATED COMPLEXES, COMPOSITIONS, METHODS AND SYSTEMS | HAO2, AOC3, OSTC | GRIN2D 2478/4885GRIN3B 742/4885GRIN1 1170/4885 |
| US-20240383856-A1 | INHIBITORS OF TRANSGLUTAMINASES | TGM2, TGM3, TGM1 | GRIN2D 2878/4885GRIN3B 2929/4885GRIN1 2076/4885 |
| US-20240376055-A1 | INHIBITORS OF TRANSGLUTAMINASES | TGM2, TGM3, TGM1 | GRIN2D 2878/4885GRIN3B 2929/4885GRIN1 2076/4885 |
| US-20240317708-A1 | INHIBITORS OF TRANSGLUTAMINASES | TGM2, TGM3, TGM1 | GRIN2D 2878/4885GRIN3B 2929/4885GRIN1 2076/4885 |
| US-20240270715-A1 | INHIBITORS OF TRANSGLUTAMINASES | TGM2, TGM3, TGM1 | GRIN2D 2878/4885GRIN3B 2929/4885GRIN1 2076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.